What is CDC guidance for disinfectant activity against Hepatitis B and Hepatitis C?
Ability of a disinfectant to inactivate M. tuberculosis var. bovis (TB) is considered a benchmark by the CDC to designate intermediate-level disinfectant activity. It makes Vital Defense-D suitable for use in healthcare and other settings where blood and other human soils are likely to be present. The CDC also states that any germicide with a tuberculocidal claim on the label is considered capable of inactivating less resistant blood borne pathogens such as HIV, Hepatitis B and Hepatitis C.